| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.08 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.084 | 0.09 |